HomeNewsBenefits & Pensions About UsContact Us

 Magazine Archives
 News Archives
 Calendar
 Money Managers
 Group Insurers
 Consultants
 Custodians
 Associations
 Careers
 Links
 Canadian Investment Review
 Canadian Healthcare Manager

Current issue is available online







The most current pension and investment information available in Canada, located in these easy to use directories. Click on any logo for information.

© Copyright 2000 Rogers Media. The following article first appeared in the March 2001 edition of BENEFITS CANADA magazine.


E-Poll

By what percentage do you expect healthcare benefits costs to increase over the next year?

Vote at benefitscanada.com

Canada's private sector spent an estimated $27.5 billion on healthcare in 2000, an increase of 5% over 1999 expenditures, according to the Canadian Institute for Health Information.

This month's E-poll shows that plan sponsors are preparing for a hefty hike in healthcare benefits costs in 2001. The majority of respondents (42%) expect costs to increase by more than 15%, while 19% expect a more modest 11% to 15% increase. Less than one-third of respondents (31%) expect an increase in their healthcare benefits costs of between 5% and 10%. Only 8% expect an increase of less than 5%.

Larry Jackson, manager of health and welfare at the Toronto office of Buck Consultants, says the 18 Canadian insurance carriers his firm surveyed expect drug costs to rise by 15.6%, dental by 8.2% and other medical by 15.2%. Jackson adds the aging population, government cost shifting and new technologies are driving this trend.

"Health costs are increasing at a faster rate than all other benefits," says Maureen Premdas, a consultant in the healthcare and group benefits practice of William M. Mercer Limited. "Expect a 15% increase in 2001. And if you do nothing, your health benefits costs alone could double within four to five years."

The main driver of cost increases is drugs. Enbrel, a drug used in the treatment of rheumatoid arthritis that was approved for sale in Canada in December, could cost up to $17,000 per patient per year. Rebetron, used in the treatment of hepatitis C, is expected to be approved for use in Canada this year at an expected cost of $19,000 per patient per year.

Joan Wade, manager of employee benefits, occupational health and safety and wellness with the Town of Richmond Hill, says the Town's plan has incurred significant increases this year. Extended healthcare costs have risen by 20% and dental premiums by 10% for 2001.

"The increase is due to two factors," she explains. "One is inflationary trends--the cost of drugs, increases in dispensing fees. And the second factor is enhancements that have been made to our benefits plans through working agreement negotiations [with employee groups]." --Young Um

Rising costs

Plan sponsors are bracing for rising healthcare benefits costs. Forty-two per cent forecast increases of more than 15%.

























Click here to enter:
6th Annual Communication Awards

Sponsored by:

 

 

The Group Internet Directory is now online. Click below to download the PDF.
English | French

The Romanow Commission has released its final report on the future of healthcare in Canada.

For Commissioner Romanow's recommendations, click here.

Click here for Senator Michael Kirby's report, "The Health of Canadians – The Federal Role: Recommendations for Reform."

About Us News Magazine Archives Benefits & Pensions
Links Careers Calender Contact UsHome